Christian Rolfo

Biography
As director of the Division of Medical Oncology at the OSUCCC Dr Rolfo oversee and support specialized units providing care and conducting research for breast, endocrine, gastrointestinal, genitourinary, lung, skin, head and neck cancers and sarcoma.As a thoracic oncologist, I largely focus on lung cancer, mesothelioma and other cancers in the chest area. My goal has always been to blend innovative, personalized treatment plans with the human touch of compassionate care.Dr Rolfo's role at the OSUCCC James also includes serving as associate director for early phase clinical trials. My goal is to ensure a patient-centered approach at every stage of discovery, as breakthroughs we make in the lab can be directly applied to patient care, and observations from patient care continually generate new research questions.Dr Rolfo's research focuses on thoracic oncology, drug development, liquid biopsy and biomarkers of cancer found in the blood, and agnostic tumors defined by molecular or genetic features rather than location in the body. My insights have contributed to the early detection of certain cancers and development of targeted drugs and therapies in these areas.In addition to my clinical and research responsibilities, Dr Rolfo is proud to support the next generation of oncologists and physician-scientists through education and mentorship as a professor of Internal Medicine at The Ohio State University College of Medicine.Dr Rolfo has worked to foster international collaboration and innovation as president of the International Society of Liquid Biopsy (ISLB) and as past chair of the Education Committee at the International Association for Study of Lung Cancer (IASLC).Dr Rolfo has made several contributions to the field through writing book chapters, serving as a book editor and authoring more than 350 scientific articles in peer-reviewed journals, including The New England Journal of Medicine, Lancet Oncology, Cancer Discovery and the Journal of Thoracic Oncology. Dr Rolfo also serve as editor-in-chief of Critical Review in Oncology Hematology.